爱尔眼科股价微涨0.16% 实控人质押1.39亿股引关注

Core Viewpoint - Aier Eye Hospital's stock price showed a slight increase, reflecting stable market performance amid significant shareholder activities and upcoming corporate governance decisions [1]. Company Overview - Aier Eye Hospital is a leading ophthalmology medical chain in China, providing services in refractive surgery, cataract treatment, and optometry [1]. - In Q1 2025, the company reported revenue of 6.026 billion yuan and a net profit attributable to shareholders of 1.05 billion yuan [1]. Shareholder Activities - The company's actual controller, Chen Bang, pledged 139 million shares, accounting for 9.63% of his holdings, while also unpledging 183 million shares [1]. - As of the announcement date, Chen Bang has a total of 212 million pledged shares, representing 2.27% of the company's total share capital [1]. Upcoming Corporate Actions - A temporary shareholders' meeting is scheduled for August 5 to discuss the completion of certain fundraising projects and the allocation of surplus funds to supplement working capital [1]. Market Activity - On August 4, the main funds experienced a net outflow of 33.0386 million yuan, with a cumulative net outflow of 2.41 billion yuan over the past five days [1].